Sanara MedTech Inc. — Board/Management Information 2012

Mar 1, 2012

8-K 1 wmti8k030112.htm WOUND MANAGEMENT TECHNOLOGIES, INC. wmti8k030112.htm Licensed to: Securities Transfer Corp Document Created using EDGARizerAgent 5.4.1.0 Copyright 1995 - 2009 Thomson Reuters. All rights reserved.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 9, 2012

Wound Management Technologies, Inc.

(Exact name of registrant as specified in its charter)

Texas	0-11808	59-2219994
(State or other jurisdiction	(Commission File	(IRS Employer
incorporation)	Number)	Identification No.)

777 Main Street, Suite 3100, Fort Worth, Texas	76102
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code 817-820-7080

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.

On February 9, 2012, Steven W. Evans informed Wound Management Technologies, Inc. (the “Company”) that because of time constraints affecting his ability to perform his duties as a director, he would be resigning as a member of the Company’s Board of Directors. His resignation was effective as of February 9, 2012. A copy of Mr. Evans’s letter of resignation has been filed with this form as Exhibit 17.1.

(d) Exhibits.

No.	Description
17.1	Resignation Letter of Steven W. Evans, dated February 9, 2012

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ Scott A. Haire
Scott A. Haire, Chief Executive Officer

3